REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Clinico de Salud Icsa S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Clinico de Salud Icsa S.A.S. Profile Updated: December 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Instituto Clinico de Salud Icsa S.A.S. is based in Colombia, with the head office in Bucaramanga. It operates in the Ambulatory Health Care Services industry. It was incorporated on October 25, 1993. It currently has a total number of 20 (2025) employees. There was a net sales revenue increase of 0.48% reported in Instituto Clinico de Salud Icsa S.A.S.’s latest financial highlights for 2024. Its total assets grew by 1.6% over the same period. In, 2024, the company’s net profit margin decreased by 1.94%.

Headquarters
Calle 39 # 22 - 62 - 48
Bucaramanga; Santander;

Contact Details: Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.
Financial Auditors:
Purchase the Instituto Clinico de Salud Icsa S.A.S. report to view the information.
Incorporation Date:
October 25, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Clinico de Salud Icsa S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
0.48%
Total operating revenue
0.48%
Net Profit (Loss) for the Period
-25.98%
Total Assets
1.6%
Total Equity
22.81%
Net Profit Margin
-1.94%
Return on Equity (ROE)
-12.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?